Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives

BMC Cancer

Table 2 Respondent characteristics.^a only described for medical and molecular specialists, not for patient representatives and policymakers. CMBP clinical molecular biologists in pathology, LSCG laboratory specialist clinical genetics

Characteristics		n
Background
	Medical specialist	7
	Medical oncologist	4
	Pulmonologist	1
	Clinical geneticist	2
	Molecular specialist	7
	Pathologist	3
	CMBP / LSCG	4
	Policymaker	3
	Patient representatives	2
Hospital setting^a
	Academic	8
	General	6
Experience with molecular diagnostics^a
	0–2 years	0
	3–5 years	2
	> 5 years	12

ISSN: 1471-2407